Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bioamber Company Profile (NASDAQ:BIOA)

Consensus Ratings for Bioamber (NASDAQ:BIOA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $18.00 (85.57% upside)

Analysts' Ratings History for Bioamber (NASDAQ:BIOA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/18/2014Societe GeneraleBoost Price Target$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014BarclaysLower Price Target$22.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014BarclaysBoost Price TargetOverweight$13.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014BarclaysBoost Price TargetOverweight$10.70 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysInitiated CoverageOverweight$10.70ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Societe GeneraleInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Credit SuisseInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Pacific CrestInitiated CoverageSector PerformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/2/2012 forward)
Discuss Bioamber